Odonate Therapeutics P/E Ratio

Odonate Therapeutics (ODT) currently reports a P/E ratio of 3227.62. That is above the Healthcare sector average of 25.72. Use the charts on this page to explore Odonate Therapeutics's P/E ratio history and peer comparisons.

Odonate Therapeutics's P/E ratio of 3227.62 is higher than the Healthcare sector average of 25.72. That is roughly 12449.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Odonate Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 3227.62, ODT can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 3227.62, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.72. From there, open related valuation or income-statement pages for Odonate Therapeutics, and consider following ODT for alerts when major investors trade the stock.

Odonate Therapeutics is classified in the Healthcare sector. On P/E ratio, it currently shows 3227.62 versus a sector average near 25.72. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ODT with unrelated industries.